Press Releases

Press Releases

    Date Title View
    12/19/13
    Summary ToggleHorizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    12/17/13
    Summary ToggleHorizon Pharma to Be Added to NASDAQ Biotechnology Index
    11/26/13
    Summary ToggleHorizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference
    11/19/13
    Summary ToggleHorizon Pharma Announces Pricing of $150 Million of 5.00% Convertible Senior Notes
    11/19/13
    Summary ToggleHorizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
    11/12/13
    Summary ToggleHorizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    11/11/13
    Summary ToggleHorizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa
    11/08/13
    Summary ToggleHorizon Pharma Announces Third Quarter 2013 Financial Results, Reports Net Revenue of $26.2 Million
    11/04/13
    Summary ToggleHorizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results on November 8, 2013
    10/29/13
    Summary ToggleHorizon Pharma Presents New Clinical Data Demonstrating RAYOS(R) (Prednisone) Delayed-Release Tablets Produce a Sustained Reduction in Morning Symptoms in Patients With Rheumatoid Arthritis
    Displaying 1 - 10 of 33 results